Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,329.50GBp
12:02pm EDT
Change (% chg)

-0.50 (-0.04%)
Prev Close
1,330.00
Open
1,329.50
Day's High
1,334.50
Day's Low
1,321.50
Volume
2,252,480
Avg. Vol
3,226,083
52-wk High
1,442.00
52-wk Low
1,173.00

Select another date:

Thu, May 3 2018

UPDATE 1-Smith & Nephew, financials knock FTSE off 3-month high

* Trade war worries weigh on global markets (Recasts, updates prices at close)

UPDATE 2-Outgoing Smith & Nephew CEO signs off with a downgrade

* Shares fall 7 pct (Adds CEO comments, analyst reaction, shares)

BRIEF-Smith & Nephew CEO says trend already improving

* CEO SAYS DECLINE IN ESTABLISHED MARKETS WAS MAINLY DUE TO MARKET WEAKNESS

Smith & Nephew downgrades outlook after weak Q1

LONDON, May 3 Smith & Nephew, Europe's biggest artificial hip and knee maker, downgraded its forecast for full-year underlying revenue growth and profit margin after some markets softened and it saw a slowdown in its bioactives business in the first quarter.

RPT-UPDATE 1-Smith & Nephew picks new CEO who sold his last company

LONDON, April 4 Artificial hip and knee maker Smith & Nephew, a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making.

Smith & Nephew names Namal Nawana new CEO

LONDON, April 4 Artificial hip and knee maker Smith & Nephew said on Wednesday it had appointed Namal Nawana to replace Olivier Bohuon as chief executive of the British company next month.

Appeals court hands win to Smith & Nephew in Hologic patent case

A federal appeals court on Wednesday upheld the validity of a surgical tool patent over which medical device maker Smith & Nephew PLC won a $4 million verdict against rival Hologic Inc.

BRIEF-Smith & Nephew Announces Full Commercial Release Of Journey II XR Total Knee Arthroplasty​

* SMITH & NEPHEW PLC - ANNOUNCES FULL COMMERCIAL RELEASE OF JOURNEY II XR TOTAL KNEE ARTHROPLASTY​ Source text for Eikon: Further company coverage:

Smith & Nephew meets lower end of guidance range for 2017

LONDON, Feb 8 Artificial hip and knee maker Smith & Nephew scraped into the bottom of its guidance range for 2017, with a 3 percent rise in revenue to $4.77 billion pounds and a 20 basis point increase in its trading margin, resulting in profit of $1.05 billion.

BRIEF-Smith & Nephew Sees Corporate Tax Rate On Trading Results In 20-21 Pct Range From 2018

* ‍AS RESULT OF US TAX CHANGE, FROM 2018 NOW EXPECTS A CORPORATE TAX RATE ON TRADING RESULTS IN RANGE 20% TO 21% FOR MEDIUM TERM​

Select another date: